RNAC - Cartesian Therapeutics Inc
9.02
2.170 24.058%
Share volume: 2,923,114
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$6.85
2.17
0.32%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-07-2024 | 03-13-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | |
| Assets | ||||||||
| Total Assets | 325.207 M | 347.738 M | 455.316 M | 435.023 M | 409.130 M | 388.893 M | 372.675 M | |
| Current Assets | 111.109 M | 124.782 M | 229.136 M | 216.626 M | 185.120 M | 163.395 M | 147.260 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.315 M | 3.472 M | 980.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 3.315 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 4.376 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 103.418 M | 87.227 M | 219.198 M | 212.610 M | 180.434 M | 160.324 M | 143.384 M | |
| Total Non-current Assets | 214.098 M | 2.000 M | 2.000 M | 2.000 M | 2.000 M | 2.000 M | 2.000 M | |
| Property Plant Equipment | 2.402 M | 6.672 M | 10.225 M | 9.912 M | 10.174 M | 12.285 M | 12.394 M | |
| Other Assets | 9.556 M | 216.284 M | 215.955 M | 208.485 M | 213.836 M | 213.213 M | 213.021 M | |
| Intangible Assets | 150.600 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 48.163 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 325.207 M | 347.738 M | 455.316 M | 435.023 M | 409.130 M | 388.893 M | 372.675 M | |
| Total liabilities | 442.007 M | 449.196 M | 454.564 M | 441.825 M | 430.919 M | 391.420 M | 408.519 M | |
| Total current liabilities | 36.654 M | 26.115 M | 21.405 M | 22.976 M | 14.998 M | 12.256 M | 13.803 M | |
| Accounts Payable | 2.517 M | 2.862 M | 517.000 K | 288.000 K | 2.097 M | 454.000 K | 2.225 M | |
| Other liabilities | 381.272 M | 407.228 M | 417.306 M | 402.708 M | 399.780 M | 363.023 M | 378.575 M | |
| Current long term debt | 2.229 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 8.228 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 381.272 M | 407.228 M | 417.306 M | 402.708 M | 399.780 M | 363.023 M | 378.575 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -116.800 M | -101.458 M | 752.000 K | -6.802 M | -21.789 M | -2.527 M | -35.844 M | |
| Common stock | 180.467 K | 560.768 M | 687.176 M | 689.890 M | 692.581 M | 695.945 M | 698.540 M | |
| Retained earnings | -671.471 M | -657.635 M | -681.818 M | -692.071 M | -709.781 M | -693.895 M | -729.797 M |